The Laryngoscope · 2025
Prognostic Role of Depth of Invasion Stratification Beyond the 10 mm Threshold in Tongue Carcinoma.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rosini Maria, Galloni Costanza, Gazzini Luca, Serafini Edorardo, Zanghi Francesca, Festa Bianca Maria, Del Giovane Cinzia, Lupi Massimo, Marchioni Daniele, Calabrese Luca, Mattioli Francesco
Аннотация
OBJECTIVES: The aim of this study is to define the prognostic role of further stratification in oral tongue and floor squamous cell carcinoma (OTFSCC) with a pathological DOI > 10 mm.
METHODS: A retrospective multicenter study was conducted on patients with a pDOI > 10 mm. Patients were stratified into three groups based on pDOI values: Group A (11-20 mm), Group B (21-30 mm) and group C (> 30 mm). The association between stratified pDOI and various histopathological features was investigated, along with disease-free survival (DFS), disease-specific survival (DSS), and overall survival (OS). Univariable and multivariable Cox regression analyses were applied to estimate the hazard ratio (HR).
RESULTS: A total of 108 patients were included. Seventy-six patients (70.4%) were in Group A, 22 (20.4%) in Group B, and 10 (9.2%) in Group C. The association between the stratified pDOI and ENE (p = 0.004), lymph node burden (LNB) (p = 0.011) and lymph node ratio (LNR) (p = 0.026) resulted statistically significant. Five-year DSS resulted in 72.5% for Group A, 53.3% for Group B, and 25.9% for Group C. Univariable analysis showed that a pDOI > 30 mm was associated with a statistically significant increased risk of recurrence (HR = 8.32, p = 0.000) and mortality from disease (HR = 3.61, p = 0.014).
CONCLUSION: The stratification of OTFSCCs with a pDOI > 10 mm was statistically significantly associated with ENE, LNB, and LNR. Pathological DOI > 30 mm emerged as a negative prognostic factor for DFS and DSS.
LEVEL OF EVIDENCE: Level 3.
METHODS: A retrospective multicenter study was conducted on patients with a pDOI > 10 mm. Patients were stratified into three groups based on pDOI values: Group A (11-20 mm), Group B (21-30 mm) and group C (> 30 mm). The association between stratified pDOI and various histopathological features was investigated, along with disease-free survival (DFS), disease-specific survival (DSS), and overall survival (OS). Univariable and multivariable Cox regression analyses were applied to estimate the hazard ratio (HR).
RESULTS: A total of 108 patients were included. Seventy-six patients (70.4%) were in Group A, 22 (20.4%) in Group B, and 10 (9.2%) in Group C. The association between the stratified pDOI and ENE (p = 0.004), lymph node burden (LNB) (p = 0.011) and lymph node ratio (LNR) (p = 0.026) resulted statistically significant. Five-year DSS resulted in 72.5% for Group A, 53.3% for Group B, and 25.9% for Group C. Univariable analysis showed that a pDOI > 30 mm was associated with a statistically significant increased risk of recurrence (HR = 8.32, p = 0.000) and mortality from disease (HR = 3.61, p = 0.014).
CONCLUSION: The stratification of OTFSCCs with a pDOI > 10 mm was statistically significantly associated with ENE, LNB, and LNR. Pathological DOI > 30 mm emerged as a negative prognostic factor for DFS and DSS.
LEVEL OF EVIDENCE: Level 3.